.
Fats are categorized as saturated, monounsaturated, and polyunsaturated and are broken down further into short-, medium-, and longchain fats; the length is determined by the number of carbons attached to the molecule. Metabolism of fatty acids is a complex process requiring bile acids, lipase, and several essential enzymes. The enzyme that is deficient in AFLP is long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD).
Approximately 19% to 25% of women in whom AFLP develops are carrying a fetus with LCHAD deficiency. 1, 3 LCHAD deficiency is an autosomal recessive disorder of mitochondrial fatty acid β-oxidation.
1,3-5
A woman heterozygous for LCHAD deficiency may be unaware she has a mutation associated with the deficiency and may be asymptomatic until late in pregnancy when AFLP 
Acute Fatty Liver of Pregnancy

Etiology
Because AFLP is related to fatty acid metabolism in the fetus, an overview of fatty acid metabolism is provided here. The 3 dietary categories that the body uses as energy A normal pregnancy can be a time filled with great expectation and joy. In contrast, a pregnancy with medical complications can be overwhelming for the expectant mother, the family, and the health care team. Acute fatty liver of pregnancy (AFLP) is a pregnancy-related disease caused by a metabolic defect in the fetus that results in acute damage of the mother's liver, putting both the expectant mother and the fetus in jeopardy.
When AFLP was first described in 1940, the mortality rate was 85%. 1 Maternal mortality was 0.13 per Acute fatty liver of pregnancy is a rare and life-threatening disease associated with a defect in fatty acid metabolism in the fetus that causes liver disease in the mother. Prompt diagnosis and management are critical to the outcome of both the mother and the fetus and require involvement of several medical specialties, including hepatology, obstetrics, and, possibly, critical care. The included case study describes a woman with acute fatty liver of pregnancy decompensating to acute liver failure complicated by encephalopathy, cerebral edema, and intracranial hypertension. Subsequent management of these conditions, including the woman's progression to liver transplant, is provided. (Critical Care Nurse. 2013;33 [1] : [48] [49] [50] [51] [52] [53] [54] [55] [56] is diagnosed. 6 However, when a heterozygous woman carries a fetus that is homozygous for such mutations, fetal fatty acids accumulate and return to the mother's circulation. The extra load of long-chain fatty acids and subsequent triglyceride accumulation lead to deposition of fat in the mother's liver and liver dysfunction. 5 
Clinical Findings and Diagnosis
Diagnosis of AFLP is difficult because common manifestations of the abnormality are nausea, vomiting, and abdominal pain, similar to symptoms experienced during a normal pregnancy and pregnancyrelated illnesses. 1 A hepatologist is crucial in making a proper and prompt diagnosis. Abnormal results of liver function tests occur in 3% to 5% of pregnancies and have many potential causes, including coincidental liver disease (hepatitis or gallstones) and underlying chronic liver disease. 3 The clinical findings of AFLP are similar to those of hemolysis, elevated liver enzyme levels, and low platelet count (HELLP) syndrome and include the following: hypoglycemia, which occurs in 79% of cases and is almost exclusive to AFLP; encephalopathy 7 (Table 2) , which occurs in 50% of cases; and jaundice 1, 8 (Table 3) . Laboratory investigations should be considered in women with nausea and vomiting without hypertension and proteinuria, and, if jaundice occurs, pale stools and dark urine. 1 Laboratory findings in women with AFLP include elevated serum levels of aspartate aminotransferase, alanine aminotransferase, total bilirubin, and lactic dehydrogenase and leukocytosis. 1, 3 Pancreatitis as a complication of AFLP is associated with poor maternal outcomes and should be ruled out because it may complicate the ability to perform any abdominal surgery, including a liver transplant. 8 Findings on liver imaging are not diagnostic for AFLP but can be used to exclude other diagnoses such as hepatic infarct or hematoma. 8 Evidence of microvesicular fatty infiltration of hepatocytes on liver biopsy specimens is diagnostic of AFLP. 3 Liver biopsy results may establish degree of liver injury and/or be used as a prognostic tool to determine the necessity of liver transplantation, but biopsy is often not performed because of coagulopathy. 
Management
Management of AFLP requires the blending of several specialties, including (but not limited to) intensive care, obstetrics, and hepatology. In an effort to alleviate the maternal hepatic overload caused by the accumulation of nonmetabolized fetal fatty acids, the treatment of AFLP is emergent delivery of the fetus. 1, 3 The mode of delivery must be carefully considered; conditions such as encephalopathy may limit the ability of the mother to participate in active labor and vaginal delivery. Results of coagulation studies should be monitored and transfusions administered as warranted. Vaginal delivery results in decreased incidence of intra-abdominal bleeding, but more commonly a cesarean delivery is performed because the latter results in a rapid, controlled birth. 1, 9 If the mother has postpartum liver dysfunction, excessive bleeding and infections can be life threatening. AFLP can be complicated by hematomas of the uterine, vulvar, and abdominal walls; obstetric hemorrhage; disseminated intravascular coagulopathy; pancreatitis; encephalopathy; and progression to acute liver failure. 1 Intensive care and aggressive treatment of organ dysfunction are required until spontaneous liver regeneration occurs. 9 Spontaneous liver regeneration and recovery after acute liver injury can occur if the inciting injury is removed or alleviated. 10 Most AFLP patients recover in 1 to 4 weeks without chronic liver dysfunction. 3 In the case study, the acute liver injury progressed to acute liver failure.
Acute Liver Failure
Acute liver failure (ALF) is defined as the rapid onset of severe liver dysfunction with coagulopathy and hepatic encephalopathy in a person without preexisting liver disease. 9, [11] [12] [13] Recognizing ALF in a patient and referring and transferring the patient to a facility with an ICU that manages patients with liver failure are important. A total of 1400 to 2000 cases per year of ALF are reported in the United States. The leading causes are acetaminophen poisoning, indeterminate causes, and idiosyncratic drug reactions. The least common cause (0.8%) is pregnancy-related illness. 12 ALF can be unpredictable and rapidly progress to multisystem organ failure. Encephalopathy, cerebral edema, sepsis, adult respiratory distress syndrome, unstable hemodynamic status, coagulopathy, marked acidosis, and acute renal failure are the main indications for ICU admission. 9, 11, 12 ALF differs from chronic liver disease; the potential for liver regeneration and recovery is possible only with ALF. Efforts are focused on sustaining a patient with ALF and the sequelae of multisystem organ failure to allow time for spontaneous liver regeneration. In general, the most important variables for predicting the outcome are the stage of encephalopathy, the patient's age, the prothrombin time or international normalized ratio, and the cause of ALF. In recent study, 8 9 of 10 patients with encephalopathy who either died or required a liver transplant (sensitivity, 90%), serum lactate levels were greater than 2.8 mg/dL. Serum lactate elevations are due to tissue hypoperfusion, tissue hypoxia, and decreased clearance associated with hepatocyte dysfunction.
ALF and Encephalopathy
Hepatic encephalopathy is defined as a neuropsychiatric disorder of altered consciousness in patients with liver disease and occurs as a result of increased intestinal production of ammonia and the shunting of portal blood to the systemic circulation. 11, 14, 15 The functional liver detoxifies ammonia; the dysfunctional liver results in increased systemic ammonia levels with subsequent increased entry of neurotoxic ammonia across the blood-brain barrier, causing encephalopathy, increased oxidative stress, and seizures. 15 The body's response to an elevated ammonia level differs between chronic liver failure and ALF. 5 Elevated ammonia levels (>150-200 μg/dL) in patients with ALF with grade 3 or grade 4 encephalopathy is associated with cerebral edema, intracranial hypertension, and brain-stem herniation. 9, 10, 12 Cerebral edema progressing to intracranial hypertension is a leading cause of mortality and morbidity in ALF. [10] [11] [12] Prevention, recognition, and management of the edema and hypertension are critical (Table 4) . Cerebral edema in ALF is multifactorial, caused by cerebral hyperammonemia, astrocyte swelling, and loss of autoregulation of cerebral blood flow, leading to cerebral hyperperfusion within the rigid skull. 5, 11, 12, 15 Most clinical signs of cerebral edema occur late in the course of the abnormality. Therefore, routine electroencephalography (seizures increase cerebral blood flow and intracranial pressure [ICP] and are often subclinical and are detected solely by using electroencephalography), 12, 15 computed tomography (CT) of the brain, transcranial Doppler studies (noninvasive ultrasound measurements of cerebral blood flow via the middle cerebral artery), jugular venous studies, and ICP monitoring (although controversial) are tools used for early detection of the edema. 5, 15 Intermittent blood gas analysis or continuous oximetry via a jugular bulb catheter can provide indirect assessment of cerebral blood flow and oxygen consumption. 5, 15, 16 Jugular venous saturation is proportional to cerebral blood flow, indicating hypoperfusion if low (<55%) and hyperperfusion if high (>85%). 9, 15 Hyperventilation-induced hypocapnia should be based on jugular bulb oxygen saturation and should be used only in cases refractory to conventional treatment. 9, 15 Epidural monitoring of ICP is used most widely because it is less invasive than monitoring by other methods and is associated with fewer complications (does not penetrate the dura). 9, 11, 16 The goals of epidural monitoring are to maintain ICP at less than 20 to 25 mm Hg and to maintain cerebral perfusion pressure between 50 and 80 mm Hg. 9, 11, 16 A norepinephrine infusion may be necessary to increase mean arterial blood pressure as intracranial pressure increases. 11, 12 The cerebral perfusion pressure can be quickly calculated by using the following formula: mean arterial pressure -ICP = cerebral perfusion pressure. 11, 12 Table 5 provides recommendations for systems management in ALF.
Case Study
The following case study highlights a pregnant woman's diagnosis of AFLP and her rapid progression to ALF. She ultimately required a liver transplant.
Day 1
A 34-year-old woman at 36 weeks' gestation with her third child had fatigue, lethargy, jaundice, and mild abdominal pain in the right upper quadrant. Table 6 gives serial Intubate and use mechanical ventilation for stages III and IV of hepatic encephalopathy, sedate with propofol and fentanyl infusions Give lactulose or saline enemas, consider oral lactulose and rifaxamin, although efficacy and safety unproven, avoid oral neomycin as it is nephrotoxic laboratory results. AFLP was diagnosed, and the priorities of treatment were to expedite delivery of the baby and transfer the mother to the ICU at the adult hospital for consultation with personnel in transplant surgery. Pitocin was used to induce labor, and an uncomplicated vaginal birth resulted in a healthy baby. Treatment of the mother with N-acetylcysteine was started. Soon after delivery, the mother became combative and agitated, indicating progression to stage 3 encephalopathy. Once she was intubated and her condition was stabilized, she was transported to the ICU. In addition to providing care specific for ALF, the ICU nursing staff mobilized resources to assist with understanding and providing for the postpartum aspects of the patient's care. Contact information was secured for quick access to the hospital's obstetric department and the nurse practitioner who served as a liaison with maternal fetal medicine in the hospital where the infant was born. The nurses were quickly educated via oral review, written material, and demonstration on assessment of the fundus of the uterus, massaging a boggy uterus, and the expected amount and appearance of lochia.
Preventive measures included placing the patient on a pressurereducing mattress in the event of ensuing complications such as increased ICP that might limit mobility. A fecal containment pouch was applied in anticipation of diarrhea induced by treatment of hyperammonemia.
Day 2
The patient was less responsive than before (stage 4 encephalopathy) and had abdominal distention. Transcranial Doppler imaging revealed optimal flow with no evidence of ischemia or hyperemia. No cerebral edema was noted on head CT scans. Abdominal CT scans revealed marked fatty infiltration of the liver, acute pancreatitis, and a postpartum uterus. A liver biopsy was performed via a transjugular approach to decrease the risk of bleeding. The biopsy samples showed 100% microvesicular steatosis with hepatocytes that appeared to be viable. Cultures of blood samples obtained on day 1 were positive for microorganisms, and appropriate antimicrobial therapy was initiated. The ICU team proceeded with actively With progression to stage III encephalopathy, intubation and mechanical ventilation for airway protection with low tidal volume ventilation to decrease the risk of acute lung injury and adult respiratory distress syndrome 9, 11, 12 Maintenance of mean arterial pressure >75 mm Hg by using (1) carefully monitored volume replacement, (2) norepinephrine infusion, (3) hydrocortisone, and (4) possibly, vasopressin 9, 11, 12 Intravenous vitamin K in an effort to correct coagulopathy because the dysfunctional liver is inferior at synthesizing clotting factors (prothrombin, fibrinogen, and factor VIII) 11, 13 (consider black box warning as well as benefit vs risk) Fresh-frozen plasma transfusion only with active hemorrhage or before invasive procedures, not prophylactically in an effort to eliminate the artificial correction of the prognostic markers for spontaneous liver recovery (prothrombin time and international normalized ratio) 5, 11, 16 Cryoprecipitate transfusion when hypofibrinogenemia is present and, possibly, administration of recombinant factor VIIa or plasmapheresis 11, 15, 16 Monitoring of serum electrolytes daily or twice a day with prompt correction, strictly avoiding hyponatremia because it may worsen cerebral edema, use of dextrose infusion because hypoglycemia is common 9, 11, 12 Intravenous N-acetylcysteine with acetaminophen overdose because it limits liver injury, improves prognosis, and improves hemodynamic parameters and oxygen delivery to tissues 9, 11, 12 Possibly N-acetylcysteine with any cause of acute liver failure 12 Intravenous histamine-2 blockers or proton pump inhibitors to decrease incidence of upper gastrointestinal bleeding 11, 12 Early enteral nutrition preferred; parenteral nutrition considered if pancreatitis is present 9, 11, 12, 16 Continuous forms of hemodialysis to prevent increase in intracranial pressure, especially in patients with unstable hemodynamic condition 9, 11, 12, 16 listing the patient for a liver transplant. The team began efforts to decrease cerebral edema. Fortunately, the patient had no complications from childbirth.
Day 3
Treatment with propofol was changed to infusion of lorazepam because of hypertriglyceridemia. The patient's family members were coping effectively with the stress of having a newborn in one hospital and the baby's mother in another hospital in critical condition. Survival of the mother and the potential need for liver transplantation were imminent concerns.
Day 4
The results of liver function tests were improving. Infusion of hypertonic saline was discontinued because the patient's serum sodium level was higher than the target range.
Day 6
Interruption of sedation coincided with a spontaneous breathing trial, although the patient was still not awake and alert. After consultation with a nutritionist, enteral feedings were started to meet the nutritional needs associated with critical illness, resolving pancreatitis, and a postpartum state.
Day 7
A nurse witnessed the patient having repetitive, rhythmic movement of an upper extremity. The movement was treated as a partial seizure responsive to lorazepam and dilantin. A consultation with the neurology service and an electroencephalogram verified the seizure activity. Consensus of the team was to begin plasmapheresis in an effort to decrease the refractory hyperammonemia and potentially decrease the triglyceride level. The patient's clinical assessment and data were interpreted by the team as evidence of increased ICP, and an epidural ICP monitor was placed. The initial ICP was 80 mm Hg. Efforts to decrease cerebral edema were started again.
Day 8
The ICP decreased, and no further electrical or muscular seizures were observed.
Day 9
Additional plasma exchanges resulted in declining ammonia and triglyceride levels. Neurological assessment revealed that the left pupil was dilated. Transcranial Doppler imaging indicated normal cerebral blood flow. A stat head CT scan indicated diffuse cerebral edema without herniation. The team decided that this patient would not recover without a liver transplant. The infectious disease service was consulted to evaluate ongoing leukocytosis. The patient was cleared for transplant with the plan to continue antibiotics even without an identified source of infection. The patient's family continued to cope effectively with this complex and emotional situation and had extended family and friends providing support and assistance. The patient's husband was balancing the joy of his baby being home, the stress of his wife's life-threatening illness, and the news of a possible donor liver. Later on day 9, the patient proceeded to surgery for a liver transplant.
Day 13
The patient's overall condition and vital signs were stable without use of vasopressors, and spontaneous breathing trials were started. The physiological stress of being postpartum, infection, critical illness, liver failure, and, ultimately, liver transplantation had left the patient malnourished. Once the pancreatitis resolved and gastric motility returned, tube feedings were resumed. The hepatic encephalopathy was resolving as indicated by decreasing ammonia levels and the clinical neurological examinations. The ICP values and the jugular oxygen saturations had been stable and within the normal range; therefore, both catheters were removed.
Day 14
The organ allograft was functioning well. The patient was awake, followed commands, and tolerated spontaneous breathing trials. The patient's family was providing updates on the baby's well-being and overall good health.
Day 16
The patient was successfully extubated and continued to improve overall despite a persistently elevated white blood cell count.
Day 17
An abdominal ultrasound showed a normal transplanted liver without ductal dilatation or perihepatic fluid collection. Personnel in maternal fetal medicine at the originating hospital were consulted about the continuously elevated white blood cell count and the possibility that the source could be a pelvic infection related to childbirth.
Day 20
An abdominal, pelvic CT scan revealed a large retroperitoneal hematoma extending to the pelvis. After consultation and review of the new clinical data, the ICU team decided to continue antibiotics and conservative treatment unless the patient's condition worsened.
Day 22
The patient remained afebrile, and finally the white blood cell count was decreasing. Dates for discontinuing antibiotic treatment were determined. The nurses reported that the patient had muscle weakness to the point that she could not move against gravity. Her affect was flat, and the nurses who were spending 12 hours a day monitoring her were unsure if the affect reflected the patient's mood (she was at risk for postpartum depression) or her physically debilitated state. Her condition had stabilized, and the team approved transition out of the ICU.
Days 23 Through 28
The intensity of physical therapy was increased, and the patient was able to tolerate sitting out of bed in a chair. The neurology service was consulted again, and electromyography studies indicated critical illness myopathy. The patient still had a flat affect despite the medical progress, family interactions, updates on her baby and other children, and the change in environment. Because she was now capable of interacting and speaking, the psychiatry service was consulted. No psychiatric diagnosis was made; her flat affect was attributed to her overall medical condition.
Day 29
All of the patient's postpartum and postoperative liver transplant issues were resolving and she was moved to an acute rehabilitation facility. She continued taking the anticipated postoperative liver transplant medications, such as tacrolimus, nystatin, acyclovir, and co-trimoxazole, in addition to the anticonvulsant levetiracetam (her immunosuppression medication can lower the seizure threshold, and the previous seizure and intracranial hypertension put her at risk for seizures).
Day 51
The patient's affect had improved, and slow resolution of the critical illness myopathy continued. The nursing plan was for her to be discharged to home today. She would continue with outpatient occupational and physical therapy. Her liver function was excellent, and she would continue outpatient visits to the transplant clinic as recommended for the rest of her life.
Update
The patient had been doing well for several years, but she relocated out of the area and no longer maintains follow-up at our transplant facility.
Conclusion
Infants of mothers with AFLP need to be tested for LCHAD deficiency in an effort to reduce morbidity and mortality. Because the diagnosis of LCHAD deficiency in the newborn can be lifesaving, all women with AFLP and their children should undergo testing for G1528C, the most common mutation associated with AFLP. 3 Testing for this variant is widely available, and testing the father for the variant should also be considered.
AFLP can recur in subsequent pregnancies in the presence or absence of the genetic mutation. Many women do not become pregnant again after AFLP, either by choice because of the critical illness or because of hysterectomy to control postpartum bleeding. 3 Women with a history of AFLP who are contemplating pregnancy should be followed up by a maternal fetal medicine specialist. CCN
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CCN Fast Facts
Facts
• Acute liver failure (ALF) is defined as the rapid onset of severe liver dysfunction with coagulopathy and hepatic encephalopathy in a person without preexisting liver disease.
• ALF can be unpredictable and rapidly progress to multisystem organ failure. Encephalopathy, cerebral edema, sepsis, adult respiratory distress syndrome, unstable hemodynamic status, coagulopathy, marked acidosis, and acute renal failure are the main indications for ICU admission.
• Cerebral edema progressing to intracranial hypertension is a leading cause of mortality and morbidity in ALF. Prevention, recognition, and management of the edema and hypertension are critical (see Table) .
• Acute fatty liver of pregnancy (AFLP) is a pregnancyrelated disease caused by a metabolic defect in the fetus that results in acute damage of the mother's liver, putting both the expectant mother and the fetus in jeopardy.
• Rare and potentially fatal, AFLP usually appears in the third trimester of pregnancy but can occur as early as 26 weeks' gestation and as late as the postpartum period.
• Diagnosis of AFLP is difficult because common manifestations are nausea, vomiting, and abdominal pain, similar to symptoms experienced during a normal pregnancy and pregnancy-related illnesses.
• The clinical findings of AFLP are similar to those of hemolysis, elevated liver enzyme levels, and low platelet count syndrome and include hypoglycemia, which occurs in 79% of cases and is almost exclusive to AFLP; encephalopathy, which occurs in 50% of cases; and jaundice.
• Management of AFLP requires the blending of several specialties, including intensive care, obstetrics, and hepatology. The treatment of AFLP is emergent delivery of the fetus.
• Spontaneous liver regeneration and recovery after acute liver injury can occur if the inciting injury is removed or alleviated. Most AFLP patients recover in 1 to 4 weeks without chronic liver dysfunction. CCN
